Insider holders · CIK 0001826457
Monte Rosa Therapeutics, Inc. · GLUE
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Markus WarmuthPresident & CEO | 585,038 | — | 585,038 | Jul 17, 2026 · 4:05 pm EDT | Form 4 |
| Sharon TownsonChief Scientific Officer | 67,845 | — | 67,845 | Jul 7, 2026 · 4:41 pm EDT | Form 4 |
| Jennifer ChampouxChief Operating Officer | 62,371 | — | 62,371 | Jul 16, 2026 · 4:10 pm EDT | Form 4 |
| Filip JankuChief Medical Officer | 60,612 | — | 60,612 | Jul 1, 2026 · 4:57 pm EDT | Form 4 |
| Anthony M. ManningDirector | 0 | — | 0 | Jun 30, 2026 · 4:05 pm EDT | Form 4 |
| Ali BehbahaniDirector | — | 0 | 0 | Jul 6, 2026 · 5:57 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.